+30.4%
GSK vs GEN
+5.4%
+25.0%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GEN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -2.2% | +0.2% | -2.0% |
| 7D | -1.8% | -1.2% | -0.6% | -1.8% |
| 30D | -2.2% | +10.1% | -12.3% | -1.9% |
| 3M | -1.8% | +16.1% | -17.9% | -1.4% |
| 6M | -10.6% | +38.9% | -49.5% | -9.7% |
| YTD | +4.4% | +14.4% | -10.0% | +5.3% |
| 1Y | +30.4% | +5.9% | +24.6% | +30.3% |
| All | +30.4% | +5.4% | +25.0% | +30.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GEN.
Daily Out/Under-Performance
Portfolio return minus GEN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GEN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GEN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling